πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 134 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6258948

Inhibitors of Interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251878

Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6239268

Interleukin-1 type 3 receptors

Neurocrine Biosciences, Inc. Β· Granted Tue May 29 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6204261

Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6191269

Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-

The Regents of the University of California Β· Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162790

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6162800

N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6136787

Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6121266

Pyridazines as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6103711

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6083503

Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases,

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063371

Pharmaceutical compositions comprising a soluble interleukin-4 receptor

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6025147

Inhibitors of interleukin-1 .beta. converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired